Ceridian HCM Holding Inc (NYSE:CDAY) Expected to Announce Earnings of $0.11 Per Share

Analysts expect that Ceridian HCM Holding Inc (NYSE:CDAY) will report earnings of $0.11 per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for Ceridian HCM’s earnings. The lowest EPS estimate is $0.10 and the highest is $0.13. Ceridian HCM reported earnings of $0.07 per share in the same quarter last year, which would suggest a positive year over year growth rate of 57.1%. The firm is scheduled to announce its next earnings results on Wednesday, February 5th.

On average, analysts expect that Ceridian HCM will report full-year earnings of $0.59 per share for the current financial year, with EPS estimates ranging from $0.47 to $1.00. For the next fiscal year, analysts forecast that the business will report earnings of $0.69 per share, with EPS estimates ranging from $0.58 to $0.84. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow Ceridian HCM.

Ceridian HCM (NYSE:CDAY) last announced its earnings results on Thursday, November 7th. The company reported $0.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.04. The company had revenue of $202.30 million during the quarter, compared to the consensus estimate of $196.52 million. Ceridian HCM had a net margin of 11.34% and a return on equity of 2.24%. Ceridian HCM’s revenue was up 13.6% compared to the same quarter last year. During the same period last year, the firm earned $0.10 earnings per share.

CDAY has been the subject of several research reports. Cantor Fitzgerald initiated coverage on shares of Ceridian HCM in a research note on Wednesday, September 11th. They set an “overweight” rating and a $65.00 price objective for the company. Zacks Investment Research downgraded shares of Ceridian HCM from a “buy” rating to a “hold” rating in a research note on Monday, October 21st. Jefferies Financial Group upgraded shares of Ceridian HCM from a “hold” rating to a “buy” rating and boosted their target price for the company from $58.00 to $65.00 in a research report on Monday, August 19th. ValuEngine downgraded shares of Ceridian HCM from a “buy” rating to a “hold” rating in a research report on Wednesday, September 4th. Finally, Mizuho set a $65.00 target price on shares of Ceridian HCM and gave the company a “buy” rating in a research report on Friday, September 6th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $57.15.

In other Ceridian HCM news, CEO David D. Ossip sold 500,000 shares of Ceridian HCM stock in a transaction on Friday, September 6th. The shares were sold at an average price of $56.00, for a total value of $28,000,000.00. Also, Director Cannae Holdings, Inc. sold 5,000,000 shares of Ceridian HCM stock in a transaction on Friday, November 15th. The shares were sold at an average price of $53.08, for a total transaction of $265,400,000.00. The disclosure for this sale can be found here. Insiders have sold 12,006,250 shares of company stock valued at $657,725,063 over the last 90 days. 26.90% of the stock is currently owned by insiders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD increased its holdings in Ceridian HCM by 31.4% in the second quarter. Price T Rowe Associates Inc. MD now owns 13,864,672 shares of the company’s stock valued at $696,007,000 after buying an additional 3,312,089 shares in the last quarter. Select Equity Group L.P. increased its holdings in Ceridian HCM by 32.4% in the third quarter. Select Equity Group L.P. now owns 8,434,199 shares of the company’s stock valued at $416,396,000 after buying an additional 2,064,472 shares in the last quarter. Vanguard Group Inc. increased its holdings in Ceridian HCM by 30.9% in the second quarter. Vanguard Group Inc. now owns 6,487,533 shares of the company’s stock valued at $325,674,000 after buying an additional 1,531,004 shares in the last quarter. BlackRock Inc. increased its holdings in Ceridian HCM by 28.6% in the second quarter. BlackRock Inc. now owns 2,913,790 shares of the company’s stock valued at $146,271,000 after buying an additional 647,177 shares in the last quarter. Finally, Bamco Inc. NY increased its holdings in Ceridian HCM by 8.2% in the second quarter. Bamco Inc. NY now owns 2,562,171 shares of the company’s stock valued at $128,621,000 after buying an additional 195,002 shares in the last quarter. 82.99% of the stock is owned by institutional investors.

Shares of NYSE:CDAY traded up $0.01 on Monday, hitting $60.37. 1,067,000 shares of the company were exchanged, compared to its average volume of 973,106. Ceridian HCM has a 1-year low of $31.39 and a 1-year high of $61.15. The stock’s 50 day moving average price is $52.25 and its 200 day moving average price is $51.64. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $8.69 billion, a P/E ratio of -1,207.40 and a beta of 1.57.

About Ceridian HCM

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

Recommended Story: Limitations to arbitrage trading

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ceridian HCM (NYSE:CDAY)

Leave a Reply

Your email address will not be published. Required fields are marked *

*